What is Abbott's 2029?

Abbott (ABT) reported 2029 of $1.7B in Q1 2026.

How has Abbott's 2029 changed year-over-year?

Abbott's 2029 increased by 142.9% year-over-year, from $700M to $1.7B.

What is the long-term trend for Abbott's 2029?

Over 3 years (2022 to 2025), Abbott's 2029 has grown at a -27.4% compound annual growth rate (CAGR), from $1.7B to $650M.

Abbott ABT 2029

2029 at other companies

MedtronicMDT

——

Medline, Inc. MDLN

——

AmgenAMGN

——

Agilent TechnologiesA

——

Merck & Co.MRK

——

Other financials

Income statement

See full

Revenue$11.2B+7.8%

Gross profit$6.3B+6.5%

Operating income$1.3B-20.6%

Net income$1.1B-18.7%

EPS (diluted)$0.61-19.7%

Balance sheet

See full

Cash & equivalents$6.8B+4.2%

Total debt$34.0B+157%

Total equity$52.1B+6.7%

Total assets$110.43B+35.6%

Cash flow

See full

Operating cash flow$1.3B-7.2%

CapEx$399.0M-17.6%

Free cash flow$916.0M-1.8%

Valuation

See full

Market cap$154.15B-22.5%

Enterprise value$181.39B-13.1%

P/E24.6×+9.8×

P/S3.4×-1.3×

Profitability

See full

Gross margin56.3%+0.4pp

Operating margin17.1%+0.2pp

Net margin13.9%-18.0pp

Returns & leverage

See full

Return on equity12.4%-18.4pp

Debt / equity0.7×+0.4×

Current ratio1.4×-0.4×

Where this comes from

Reported directly by Abbott in its filing.

Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree.

The official record: Abbott’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Abbott's 2029.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Abbott's 2029?: Abbott (ABT) reported 2029 of $1.7B in Q1 2026.
How has Abbott's 2029 changed year-over-year?: Abbott's 2029 increased by 142.9% year-over-year, from $700M to $1.7B.
What is the long-term trend for Abbott's 2029?: Over 3 years (2022 to 2025), Abbott's 2029 has grown at a -27.4% compound annual growth rate (CAGR), from $1.7B to $650M.